AusperBio to Present Two Posters on AHB-137, a Novel Antisense Oligonucleotide for Hepatitis B at EASL™ Congress 2023
/PRNewswire/ -- Ausper Biopharma Co., Ltd. And AusperBio Therapeutic, Inc. (Together AusperBio), a clinical-stage biotechnology company, today announces the...